Pituitary Neoplasms
📧 Sign up to get email alerts when something new happens for Pituitary Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Hypofractionated Radiosurgery to Treat Residual/Recurrent Non Secreting Pituitary Adenoma (HYPOADENO) [NA]
A completed clinical trial evaluating hypofractionated radiosurgery to treat residual or recurrent non-secreting pituitary adenomas (HYPOADE…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Long Term Outcome Study in Patients With Pituitary Disorders
A long-term outcome study in patients with pituitary disorders is being conducted, sponsored by the University of Alberta. The trial status …
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Clinical Evaluation of [68Ga]Ga-NOTA-RF PET Imaging Targeting RFVT3 in Patients With Pituitary Tumors [EARLY_Phase 1]
This early-phase clinical trial update describes an imaging study evaluating the Ga-68 labeled NOTA-RF PET tracer targeting RFVT3 in patient…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery [NA]
A clinical trial investigating augmented reality neuronavigation for transnasal endoscopic skull base surgery in patients with pituitary neo…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Clinical-pathological Evaluation of Pit-NETs
This clinical trial update describes a study evaluating the clinical and pathological features of pituitary neuroendocrine tumors (Pit-NETs)…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: Hyponatremia Study (Delayed Hyponatremia After Pituitary Surgery) [NA]
This completed clinical trial evaluated delayed hyponatremia after pituitary surgery.
-
CLINICAL_TRIALS trial_result · 2021-03-29Clinical Trial Update: Da Vinci Transoral Robotic-assisted Surgery of Pituitary Gland [NA]
Clinical trial update for Da Vinci transoral robotic-assisted surgery targeting pituitary neoplasms; study is terminated with results posted…
-
CLINICAL_TRIALS research · 2016-10-12Clinical Trial Update: Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery [Phase 4]
A Phase 4 clinical trial evaluating whether dexmedetomidine alters plasmatic cortisol response during transsphenoidal surgery in patients wi…
-
CLINICAL_TRIALS trial_result · 2016-07-26Clinical Trial Update: Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin [Phase 2]
Phase 2 study of pasireotide in rare neuroendocrine-origin tumors was terminated and results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: Follow-up Evaluation of Photo-Dynamic Therapy for Pituitary Tumours
This update presents follow-up results from a completed clinical trial evaluating photo-dynamic therapy for pituitary neoplasms.
-
CLINICAL_TRIALS research · 2015-07-31Clinical Trial Update: Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools [NA]
A clinical trial update from Unity Health Toronto assessing patient education tools for pituitary disorders; no phase or results information…
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions [Phase 4]
Phase 4 clinical trial update evaluating whether perioperative glucocorticoid replacement improves prognosis after surgery for sellar lesion…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Evaluation of Factors in Human Brain Tumors
A completed NINDS clinical trial evaluated factors in human brain tumors, including glioblastoma, glioma, and pituitary neoplasms.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Sandostatin LAR Depot vs. Surgery for Treating Acromegaly [Phase 2]
A Phase 2 trial comparing Sandostatin LAR Depot to surgery for acromegaly has completed.